Furthermore, high HMGB1 expression corelated with poorer response to neoadjuvant chemoradiation in rectal cancer patients, albeit in a small cohort who failed to achieve a complete response and there was no assessment of expression pre- and post-treatment (see supplementary Table 2). This evidence concerns the gene HMGB1 and rectal cancer.